<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5552660</article-id><article-id pub-id-type="doi">10.3389/fimmu.2017.00945</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Neuroimmune Interactions in Inflammation and Acute Kidney Injury</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Inoue</surname><given-names>Tsuyoshi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/451387"/></contrib><contrib contrib-type="author"><name><surname>Tanaka</surname><given-names>Shinji</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Okusa</surname><given-names>Mark D.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/447744"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Division of Nephrology, Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia</institution>, <addr-line>Charlottesville, VA</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Valentin A. Pavlov, Northwell Health, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Benjamin Ethan Steinberg, University of Toronto, Canada; Bruno Bonaz, Universit&#x000e9; Grenoble Alpes and Centre Hospitalier Universitaire de Grenoble, France; Colin Reardon, University of California, Davis, United States</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Mark D. Okusa, <email>mdo7y@virginia.edu</email></corresp><fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>09</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>8</volume><elocation-id>945</elocation-id><history><date date-type="received"><day>15</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>24</day><month>7</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 Inoue, Tanaka and Okusa.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Inoue, Tanaka and Okusa</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Inflammation contributes to the pathogenesis of a wide variety of disorders including kidney diseases. Recent advances have shown that neural pathways are able to regulate immunity and inflammation. The cholinergic anti-inflammatory pathway (CAP) is a well-studied neural circuit involving the vagus nerve that is thought to contribute to the response to inflammatory disorders. Expression of receptors for neurotransmitters is found in some immune cells, including &#x003b2;2 adrenergic receptors on CD4 T cells and alpha 7 subunit of the nicotinic acetylcholine (ACh) receptor on macrophages. Once nerves are activated, neurotransmitters such as norepinephrine and ACh are released at nerve terminals, and the neurotransmitters can activate immune cells located in close proximity to the nerve terminals. Thus, vagus nerve stimulation induces activation of immune cells, leading to an anti-inflammatory response. Recent studies demonstrate a non-pharmacological organ protective effect of electrical nerve stimulation, pulsed ultrasound treatment, or optogenetic C1 neuron activation. These modalities are thought to activate the CAP and attenuate inflammation. In this review, we will focus on the current understanding of the mechanisms regarding neuroimmune interactions with a particular focus on inflammation associated with kidney disease.</p></abstract><kwd-group><kwd>neuroimmunomodulation</kwd><kwd>immunity</kwd><kwd>inflammation</kwd><kwd>vagus nerve</kwd><kwd>kidney injury</kwd></kwd-group><funding-group><award-group><funding-source id="cn01">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source><award-id rid="cn01">1R01DK105133 and R01 DK062324 and NIH awards U18EB021787 and 1S10RR026799-01</award-id></award-group></funding-group><counts><fig-count count="2"/><table-count count="0"/><equation-count count="0"/><ref-count count="78"/><page-count count="7"/><word-count count="6023"/></counts></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><p>Recent advances have shown that the communication between the nervous and immune systems can regulate immune function and inflammation (<xref rid="B1" ref-type="bibr">1</xref>). The link between the nervous and immune systems depends in part on neural reflexes involving various immune cells. Receptors for neurotransmitters such as acetylcholine (ACh) and norepinephrine (NE) are found on macrophages, dendritic cells, T cells, and B cells (<xref rid="B2" ref-type="bibr">2</xref>). These immune cells synthesize and release neurotransmitters and respond to neurotransmitters released from nearby nerve terminals and other immune cells (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). This link between the nervous and immune systems permits rapid homeostatic responses to inflammation and is poised to mediate protection from organ injury. This review will summarize our understanding of the molecular mechanisms that underlie the neural control of inflammation in experimental models of inflammation, mainly focusing on acute kidney injury (AKI) as well as in early studies in human diseases.</p></sec><sec id="S2"><title>Cholinergic Anti-Inflammatory Pathway (CAP)</title><p>A well-studied neuroimmune pathway is the CAP, the efferent limb of the &#x0201c;inflammatory reflex pathway&#x0201d; mediated through the vagus nerve. This concept has been described by Tracey et al. using a lipopolysaccharide (LPS) model of inflammation (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B5" ref-type="bibr">5</xref>&#x02013;<xref rid="B8" ref-type="bibr">8</xref>). Peripheral vagal afferent neurons express receptors in proximity to immune cells and detect bacterial products (pathogen-associated molecular patterns), proinflammatory cytokines, immunoglobulins and ATP through receptors (<xref rid="B9" ref-type="bibr">9</xref>&#x02013;<xref rid="B16" ref-type="bibr">16</xref>). Following detection of these inflammatory molecules, receptors transduce signals from the immune cells and injured tissue and transmit them to the brainstem nucleus tractus solitarius (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B17" ref-type="bibr">17</xref>). Through uncertain mechanisms vagus efferent nerve is activated and the inflammatory reflex controls peripheral cytokine levels and inflammation.</p><p>Mononuclear phagocytes and CD4 T cells are key cellular components that interact to mediate the anti-inflammatory response following activation of CAP. Tracey et al. initially found that direct electrical stimulation of efferent vagus nerve significantly decreased the amount of tumor necrosis factor alpha (TNF-&#x003b1;) in the serum induced by LPS (<xref rid="B8" ref-type="bibr">8</xref>). The effect was abolished in mice deficient in the alpha 7 subunit of the nicotinic acetylcholine receptor (&#x003b1;7nAChRKO). &#x003b1;7nAChR is predominantly expressed in neuronal tissues, but Tracey et al. provided histological and functional evidence for &#x003b1;7nAChR on macrophages (<xref rid="B11" ref-type="bibr">11</xref>). LPS-induced TNF-&#x003b1; production in peritoneal macrophages was suppressed by ACh or nicotine, an agonist for the nicotinic receptor, and its suppression was abolished in peritoneal macrophages derived from &#x003b1;7nAChRKO mice (<xref rid="B18" ref-type="bibr">18</xref>). Downstream of &#x003b1;7nAChR, inhibition of the nuclear translocation of NF-&#x003ba;B (<xref rid="B19" ref-type="bibr">19</xref>) and activation of the JAK2&#x02013;STAT3 pathway (<xref rid="B20" ref-type="bibr">20</xref>) ultimately reduces the production of inflammatory mediators.</p><p>CD4 T cells importantly contribute to the anti-inflammatory response following activation of CAP. Vida et al. revealed a role for &#x003b2;2 adrenergic receptors on CD4 T cells (<xref rid="B21" ref-type="bibr">21</xref>). They showed that the &#x003b2;2 antagonist butoxamine efficiently reversed the TNF-&#x003b1; suppression induced by vagus nerve stimulation (VNS). Furthermore, the anti-inflammatory effect of VNS was lost in &#x003b2;2 adrenergic receptor-deficient mice, but the VNS-induced effect was rescued by the transfer of CD4<sup>+</sup> CD25<sup>&#x02212;</sup> cells (non-T regulatory cells) and not CD4<sup>+</sup> CD25<sup>+</sup> cells from WT mice (<xref rid="B21" ref-type="bibr">21</xref>). These results provide molecular and pharmacological evidence for the role of CD4<sup>+</sup> cells in contributing to the anti-inflammatory effect of CAP.</p><p>In addition to the importance of macrophages and CD4 T cells, it became evident that the spleen was a crucial organ in the CAP (<xref rid="B22" ref-type="bibr">22</xref>). Huston et al. revealed that the spleen is the major source of TNF-&#x003b1; after LPS challenge, and VNS-induced inhibition of systemic TNF-&#x003b1; production was abolished in splenectomized animals (<xref rid="B22" ref-type="bibr">22</xref>).</p><p>The splenic nerve, a component of the sympathetic (adrenergic) nervous system, releases NE, whereas the vagus nerve, a component of the parasympathetic (cholinergic) nervous system, releases ACh at nerve terminals upon activation. In response to VNS, ACh in the spleen (<xref rid="B3" ref-type="bibr">3</xref>) and NE in plasma (<xref rid="B21" ref-type="bibr">21</xref>) are upregulated. Rodent spleen receives noradrenergic fibers from the splenic sympathetic nerves, but little or no direct (cholinergic) innervation from the vagus was found in the spleen (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>). Rosas-Ballina et al. elegantly showed that spleen CD4<sup>+</sup> CD44<sup>high</sup> CD62L<sup>low</sup> cells, which express choline acetyltransferase (ChAT) and can release ACh, are the source of ACh in spleen during activation of CAP (<xref rid="B3" ref-type="bibr">3</xref>). Catecholaminergic terminals of the splenic nerve in the white pulp of the spleen are in close proximity to lymphocytes, including ChAT-positive T cells, thus permitting functional coupling. The anti-inflammatory effects of VNS are abolished in nude mice, which do not have functional T cells, however reconstituting T cells through adoptive transfer of ACh-synthesizing T lymphocytes into nude mice partially restores VNS-induced anti-inflammatory effect (<xref rid="B3" ref-type="bibr">3</xref>). These experiments explain how ACh levels are elevated in the spleen after VNS despite the lack of direct vagus innervation of the spleen. Still unresolved, however, is how NE is released in the spleen (or systemically) after VNS, information that would clarify the interaction between vagus (parasympathetic, cholinergic) and splenic (sympathetic, adrenergic) nerve in CAP. Figure <xref ref-type="fig" rid="F1">1</xref> characterizes the CAP based upon current information and Figure <xref ref-type="fig" rid="F2">2</xref>A summarizes the methods to activate the CAP.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Cholinergic anti-inflammatory pathway (CAP). The CAP links the nervous system and immune system. The activity of afferent vagus nerve fibers is stimulated by cytokines and pathogen-associated molecular pattern molecules. The signal activates efferent vagus nerve fibers through the nucleus tractus solitarius (NTS) and dorsal motor nucleus of the vagus in the brain. The efferent vagus nerve (cholinergic) stimulates CD4 T cells in spleen via the splenic sympathetic (adrenergic) nerve. Release of norepinephrine binds to &#x003b2;2-adrenergic receptors (&#x003b2;2ARs) on CD4 T cells, which then elicits release of acetylcholine (ACh). ACh binding to alpha 7 nicotinic acetylcholine receptors (&#x003b1;7nAChRs) on macrophages produces an anti-inflammatory response, such as TNF-&#x003b1; suppression. Ultrasound and C1 neuron stimulation also activate the pathway and produce organ protective effects.</p></caption><graphic xlink:href="fimmu-08-00945-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>The summary of the methods to activate the cholinergic anti-inflammatory pathway (CAP). <bold>(A)</bold> The list of the methods to activate the CAP. <bold>(B)</bold> Photosensitive ion transporters (used for optogenetic stimulation). When blue (yellow) light is applied to neurons expressing channelrhodopsin (halorhodopsin), the opsin functions as a non-selective cation channel (a chloride pump), resulting in excitation (inhibition) of the neurons.</p></caption><graphic xlink:href="fimmu-08-00945-g002"/></fig></sec><sec id="S3"><title>AKI and Inflammation</title><p>Acute kidney injury is a sudden loss of kidney function that occurs within a few hours or up to a few days after an insult and is accompanied by inflammation and tissue damage. AKI causes life-threatening complications such as fluid overload, hyperkalemia, uremia, and metabolic acidosis and can also have systemic effects on other organs including brain, heart, and lung. In hospitalized patients, AKI is a common and major concern because of its high morbidity and mortality (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>). In addition, there is a high prevalence of AKI in emergency department patients (<xref rid="B27" ref-type="bibr">27</xref>). Various factors such as ischemia, drugs, toxins and infections cause AKI, and inflammation plays a major role in the pathophysiology of AKI including aseptic or sterile AKI (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>). The role of immune cells differ depending on the causes of AKI (<xref rid="B30" ref-type="bibr">30</xref>). As ischemia&#x02013;reperfusion injury (IRI) is one of the major causes of AKI and has been studied most extensively, the involvement of both innate and adaptive immunity has been revealed in renal IRI (<xref rid="B29" ref-type="bibr">29</xref>&#x02013;<xref rid="B31" ref-type="bibr">31</xref>) as described below.</p><p>Following renal ischemia&#x02013;reperfusion, much of the inflammation occurs in the outer medulla, the part of the kidney with the lowest oxygen tension and with the greatest degree of epithelial cell necrosis. Damage-associated molecular patterns released from dying cells, adhesion molecules, and Toll-like receptors induce the recruitment and activation of various immune cells during the early injury phase (<xref rid="B30" ref-type="bibr">30</xref>). Recruitment of neutrophils, natural killer (NK) cells, and NK T cells occurs within several hours of tissue injury, and these cells contribute to initiation of the inflammatory cascade such as IL-1, IL-6, and TNF-&#x003b1;. Leukocyte infiltration into postischemic regions in the kidney is promoted by activation of the complement system in addition to enhanced proinflammatory cytokines and chemokines production (<xref rid="B32" ref-type="bibr">32</xref>). Renal dendritic cells increase in number in the injury site and mediate inflammation from the early to late injury phase. Inflammatory monocytes infiltrate the injury site subsequently to neutrophils infiltration and they differentiate into macrophages. In the injury phase, macrophages are polarized into proinflammatory macrophages (M1) and cause tissue damage. By contrast, anti-inflammatory macrophages (M2) predominate during the recovery phase and contribute to resolution of inflammation and tissue repair (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Tregs play important roles in tubular regeneration, promoting the repair from ischemic injury in addition to their intrinsic renal protective function (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>). B cells are activated in the injury phase and limit tubular regeneration in the recovery phase, leading to tubular atrophy (<xref rid="B36" ref-type="bibr">36</xref>).</p></sec><sec id="S4"><title>VNS in Kidney Disease</title><p>Inoue et al. evaluated the role of VNS in AKI (<xref rid="B37" ref-type="bibr">37</xref>). When VNS was performed 24&#x02009;h prior to IRI, renal function and tissue morphology were preserved. Plasma TNF-&#x003b1; induction by IRI was also suppressed by prior VNS. Interestingly, this renal protection was observed after either afferent or efferent VNS. Vagus efferents on the opposite side were activated by stimulating vagal afferents on the left side (<xref rid="B37" ref-type="bibr">37</xref>). However, the kidney was still protected form IRI by left afferent vagal stimulation with the right vagal nerve blocked with local anesthetic. These findings suggest that afferent VNS and efferent VNS might protect the kidney through different mechanisms. Studies to dissect separate vagal pathways using optogenetic approaches would provide new mechanistic information.</p><p>Splenic &#x003b1;7nAChR-positive cells contribute to VNS-induced kidney protection. Splenocytes harvested from WT or &#x003b1;7nAChRKO donor mice 24&#x02009;h after VNS or sham VNS treatment were transferred into naive WT recipient mice. The recipient mice received renal IRI 24&#x02009;h later. When the mice received splenocytes from VNS-treated WT mice, the recipient mice were protected from IRI. However, no protection was observed when the recipient mice obtained splenocytes from VNS-treated &#x003b1;7nAChRKO mice (<xref rid="B37" ref-type="bibr">37</xref>). The number of macrophages in the kidney increased with time after IRI, but there was no difference in number between WT and &#x003b1;7nAChRKO mice. On the other hand, prior VNS seems to change the polarizing phenotype of macrophages in the kidney. IRI alone induced all M1 markers and most of M2 markers we measured, but suppressed Arg1 expression (an M2 marker) in the infiltrated macrophages in the kidney. Prior VNS rescued Arg1 expression in WT mice, but not in &#x003b1;7nAChRKO mice (<xref rid="B37" ref-type="bibr">37</xref>). Thus, VNS-induced protection from kidney injury requires &#x003b1;7nAChR-positive splenocytes and the phenotypic change of macrophages toward M2 might be one mechanism of the protection by VNS.</p><p>Inflammation and activation of immune system are also involved in the initiation and development of other kidney diseases such as glomerulonephritis, lupus nephritis, and diabetic nephropathy (<xref rid="B38" ref-type="bibr">38</xref>&#x02013;<xref rid="B40" ref-type="bibr">40</xref>). Depending on the phases and types of the kidney diseases, different immune cells, cytokines, and chemokines participate in the pathogenesis of the disease. The involvement of T cells (<xref rid="B41" ref-type="bibr">41</xref>) and macrophages (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B42" ref-type="bibr">42</xref>), key components of the CAP, is reported in various kidney disorders. With rare exception, there are no reports that VNS was applied to the other kidney diseases. VNS was applied to brain dead donors in a model of kidney transplantation (<xref rid="B43" ref-type="bibr">43</xref>). VNS stimulation of brain dead donors led to an improvement in transplanted kidney histology and renal function at 16&#x02009;weeks posttransplantation when compared to unstimulated group. These preclinical data undergird the use of VNS in clinical trials of kidney transplantation. There are limited studies in kidney diseases; however, based on the importance of inflammation and immune responses in these disorders, we believe that many kidney diseases may serve as important therapeutic targets of VNS.</p></sec><sec id="S5"><title>Ultrasound (US) Protects from AKI Through the CAP</title><p>Gigliotti et al. found that prior US application (1&#x02009;s every 6&#x02009;s for 2&#x02009;min on the both sides of kidneys including spleen, mechanical index of 1.2) suppressed systemic and local (renal) inflammation such as IL-6 and TNF-&#x003b1;, and attenuated AKI (<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>). Experiments in splenectomized mice revealed that the spleen is required for US-induced renal protection (<xref rid="B44" ref-type="bibr">44</xref>). US-induced protection was also observed in a cecal ligation and puncture-induced sepsis model (<xref rid="B45" ref-type="bibr">45</xref>). Prior US treatment did not protect the kidney in Rag1-deficient mice (Rag1KO) that lack T and B lymphocytes. However, when the Rag1KO were reconstituted with CD4 T cells 10&#x02009;days prior to US treatment, the protective effect of US was restored (<xref rid="B44" ref-type="bibr">44</xref>). In addition, adoptive transfer of splenocytes from US-treated mice 24&#x02009;h prior to IRI confers protection from IRI (<xref rid="B45" ref-type="bibr">45</xref>). These data indicate that CD4 T cells in the spleen are important for US-mediated renal protection.</p><p>To investigate whether the protective effects of US were mediated through &#x003b1;7nAChR signaling in CAP, &#x003b1;7nAChRKO mice were used. In &#x003b1;7nAChRKO mice, treatment with US before IRI did not provide protection (<xref rid="B44" ref-type="bibr">44</xref>). Bone marrow chimera experiments further revealed the importance of &#x003b1;7nAChRs on hematopoietic cells in US-related organ protection (<xref rid="B45" ref-type="bibr">45</xref>). Taken together, these findings suggest that US protects the kidney from AKI through activation of the CAP.</p></sec><sec id="S6"><title>VNS and Other Neuroimmune Reflexes in Various Disorders</title><p>Following initial studies on LPS-mediated inflammation, anti-inflammatory effects of VNS in a wide variety disorders such as arthritis (<xref rid="B46" ref-type="bibr">46</xref>), colitis (<xref rid="B47" ref-type="bibr">47</xref>), ileus (<xref rid="B47" ref-type="bibr">47</xref>), pancreatitis (<xref rid="B48" ref-type="bibr">48</xref>), heart disease (<xref rid="B49" ref-type="bibr">49</xref>), diabetes (<xref rid="B50" ref-type="bibr">50</xref>), and hypertension (<xref rid="B51" ref-type="bibr">51</xref>) were confirmed. In contrast to the spleen, the vagus efferent fibers innervate the intestinal wall and directly synapse with postganglionic neurons in the enteric nervous system (<xref rid="B52" ref-type="bibr">52</xref>). VNS improves colitis (<xref rid="B53" ref-type="bibr">53</xref>) and ileus (<xref rid="B54" ref-type="bibr">54</xref>), and vagotomy aggravates these conditions (<xref rid="B55" ref-type="bibr">55</xref>). The vagus nerve does not directly innervate the joints; however, VNS attenuated limb inflammation following acute carrageenan-induced arthritis, and vagotomy resulted in increased acute inflammation as evidenced by severe edema (<xref rid="B56" ref-type="bibr">56</xref>). Chronic stimulation of vagus nerve, using a method called vagus nerve suspension, improved arthritic scores 3&#x02009;months after the second immunization in a collagen-induced arthritis model (<xref rid="B57" ref-type="bibr">57</xref>). In addition, chronic electrical stimulation of vagus nerve (once daily from day 9 to day 15 for 60&#x02009;s), using an implanted device with vagus nerve cuff electrodes, reduced the severity of collagen-induced arthritis in rats at day 16 (<xref rid="B58" ref-type="bibr">58</xref>).</p><p>On the other hand, there are many reports implying the existence of different reflexes and pathways other than the classical CAP. Sciatic nerve activation with electroacupuncture suppresses systemic inflammation following polymicrobial peritonitis through activation of the vagus nerve (<xref rid="B59" ref-type="bibr">59</xref>). Stimulation of the sciatic nerve induces vagal-mediated production of aromatic <sc>l</sc>-amino acid decarboxylase in the adrenal medulla leading to the production of dopamine thereby suppressing systemic inflammation through dopamine type 1 (D1) receptors. Recent studies revealed the importance of sympathetic (adrenergic) nerves (splanchnic and splenic nerves) in a neural reflex pathway that controls inflammation (<xref rid="B60" ref-type="bibr">60</xref>). LPS administration strongly increased splanchnic nerve and its splenic branch activity in addition to systemic TNF-&#x003b1; production. LPS-induced increase in plasma TNF-&#x003b1; was enhanced nearly five times when splanchnic nerve was cut, and vagotomy did not affect this. Plasma corticosterone levels were not affected by splanchnic nerve cut, suggesting that in this particular model the neural reflex pathway controlling inflammation was independent of corticosteroids and the vagus nerve. ACh-producing B lymphocytes control local neutrophil recruitment to the peritoneum in response to endotoxin (<xref rid="B61" ref-type="bibr">61</xref>). Finally, recent studies suggest a role of &#x003b2;2-adrenergic receptors on the muscularis macrophages, localized deeper in the gut wall (<xref rid="B62" ref-type="bibr">62</xref>). Upon luminal bacterial infection, sympathetic (adrenergic) neurons innervating the gut are activated, then muscularis macrophages further enhance tissue-protective programs through &#x003b2;2-adrenergic receptors on the macrophages (<xref rid="B62" ref-type="bibr">62</xref>).</p></sec><sec id="S7"><title>Optogenetic Approaches to Defining the Mechanism of the CAP</title><p>Optogenetics is a technique involving the use of light to control the activity of neurons that have been genetically modified to express photosensitive ion transporters (Figure <xref ref-type="fig" rid="F2">2</xref>B) (<xref rid="B63" ref-type="bibr">63</xref>). The discovery of channelrhodopsin-1 (<xref rid="B64" ref-type="bibr">64</xref>) and -2 (<xref rid="B65" ref-type="bibr">65</xref>) (ChR1 and ChR2) in 2002 and 2003, respectively, marked the genesis of optogenetics. These unique opsins are found in the &#x0201c;eye spot&#x0201d; of <italic>Chlamydomonas reinhardtii</italic>. When blue light (~470&#x02009;nm) is applied to ChR2, the channel opens and functions as a non-selective cation channel. Only 2&#x02009;years after the discovery of ChR2, investigators introduced it in mammalian neurons, which were then successfully stimulated using blue light (<xref rid="B66" ref-type="bibr">66</xref>).</p><p>The utilization of halorhodopsin, an inhibitory channel, gave further impetus to studies using optogenetics (<xref rid="B67" ref-type="bibr">67</xref>). When yellow light (~590&#x02009;nm) is applied to neurons expressing halorhodopsin, the pump allows chloride ions to enter the cells, thereby resulting in hyperpolarization and inhibition of the neurons. In addition, by using the Cre-Lox system, these excitatory or inhibitory proteins can be introduced into specific cell types. Thus, optogenetics enables targeted excitation or inhibition, conferring cellular or projection specificity, which is not attainable through electrical stimulation. Owing to its significant impact on studies in neuroscience, this technique was selected as the &#x0201c;Method of the Year&#x0201d; by the Nature publishing group in 2010 (<xref rid="B68" ref-type="bibr">68</xref>).</p><p>Because of the many advantages optogenetics provides, this technique is especially useful for revealing the mechanism of the CAP, although it has been underutilized for this purpose thus far. For example, vagal afferent sensory neurons have been divided into several subgroups based on specific markers, and optogenetic stimulation of each subgroup modulated the function of the lung, heart, and gastrointestinal tract in different ways. Selective activation of P2ry1-positive and Npy2r-positive neurons in vagal afferents resulted in apnea and rapid/shallow breathing, respectively (<xref rid="B69" ref-type="bibr">69</xref>). It was also reported that Gpr65-positive neurons innervating intestinal villi detect nutrients and regulate gut motility, while Glp1r-positive neurons sense stomach and intestine stretch (<xref rid="B70" ref-type="bibr">70</xref>). These findings suggest that nerves in the CAP such as vagus nerve and splenic nerve can be divided into several subgroups and each subgroup might have different roles in the CAP and that optogenetics has the high potential to facilitate elucidation of the selective neural circuits of the CAP.</p></sec><sec id="S8"><title>C1 Neurons and Restraint Stress in the CAP</title><p>By using optogenetics, Abe et al. revealed a new role of C1 neurons in activating the CAP (<xref rid="B71" ref-type="bibr">71</xref>). C1 neurons, which reside in the medulla oblongata and innervate the dorsal motor nucleus of the vagus nerve, sympathetic (adrenergic) efferents, the paraventricular nucleus of the hypothalamus, and other brainstem regions, mediate adaptive autonomic responses to several stressors, such as hypotension, hypoxia, and LPS (<xref rid="B72" ref-type="bibr">72</xref>). C1 neurons stimulation by laser protects mouse kidneys from IRI. The spleen, &#x003b2;2-adrenergic receptors, and &#x003b1;7nAChRs are necessary for the protective effect, thereby suggesting that the CAP is involved in the protective effect of C1 neuron stimulation. Interestingly, restraint stress for 10&#x02009;min also protects the kidney from IRI. The protective effect is mediated by C1 neurons and was abolished by ganglionic blockade but not affected by subdiaphragmatic vagotomy or by corticosterone receptor blockade. These findings suggest that C1 neurons activate the CAP not through a vagal, but through a sympathetic (adrenergic) route.</p></sec><sec id="S9"><title>Vagus Nerve Stimulator</title><p>More than 100,000 vagus nerve stimulators have been implanted for medically refractory epilepsy and for treatment-resistant depression and the device has been well tolerated (<xref rid="B73" ref-type="bibr">73</xref>). Although transvenous VNS failed to suppress systemic inflammation in healthy subjects (<xref rid="B74" ref-type="bibr">74</xref>), pilot studies have showed that implanted vagus nerve stimulators are effective in rheumatoid arthritis (<xref rid="B75" ref-type="bibr">75</xref>) and Crohn&#x02019;s disease (<xref rid="B76" ref-type="bibr">76</xref>) in human. In 17 patients with rheumatoid arthritis, including those in early and late stages of the disease, symptoms improved significantly during the period of VNS (<xref rid="B75" ref-type="bibr">75</xref>). Biological parameters, including endoscopic index of severity, improved in seven patients with Crohn&#x02019;s disease and treated with VNS in a 6-month follow-up (<xref rid="B76" ref-type="bibr">76</xref>). In addition, many other clinical trials on a wide variety of disorders such as heart failure, hypertension, inflammation, and diabetes are ongoing. Recently two non-invasive external devices have been developed to stimulate the vagus nerve through the skin (<xref rid="B73" ref-type="bibr">73</xref>). Transcutaneous cervical VNS reduced the extent of tissue damage after cerebral ischemic injury in rats (<xref rid="B77" ref-type="bibr">77</xref>). In humans, VNS with a transcutaneous device on the neck downregulated release of inflammatory cytokines, such as IL-1&#x003b2; and TNF-&#x003b1;, in healthy subjects (<xref rid="B78" ref-type="bibr">78</xref>).</p></sec><sec id="S10"><title>Conclusion</title><p>In summary, neuroimmune interactions play very important roles in various disorders, however the mechanisms linking these two different systems are very complex and incompletely understood. Additional studies using advanced tools such as optogenetics will lead to further molecular understanding of neuroimmunomodulatory mechanisms controlling inflammation. These studies could yield potent non-pharmacological approaches to blocking inflammation and tissue injury in systemic disease. In the future, vagus nerve stimulator or US treatment might be applied to the patients who are planned to have cardiac surgery or kidney transplantation, conditions that result from renal ischemia injury.</p></sec><sec id="S11"><title>Author Contributions</title><p>All authors participated in the writing, editing, and literature search. ST was responsible for Figure <xref ref-type="fig" rid="F2">2</xref> and TI was responsible for Figure <xref ref-type="fig" rid="F1">1</xref>.</p></sec><sec id="S12"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> Research summarized in this review was supported by the National Institutes of Health under awards 1R01DK105133, R01DK062324, U18EB021787 and 1S10RR026799-01.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlov</surname><given-names>VA</given-names></name><name><surname>Tracey</surname><given-names>KJ</given-names></name></person-group>. <article-title>Neural regulation of immunity: molecular mechanisms and clinical translation</article-title>. <source>Nat Neurosci</source> (<year>2017</year>) <volume>20</volume>(<issue>2</issue>):<fpage>156</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1038/nn.4477</pub-id><?supplied-pmid 28092663?><pub-id pub-id-type="pmid">28092663</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawashima</surname><given-names>K</given-names></name><name><surname>Fujii</surname><given-names>T</given-names></name><name><surname>Moriwaki</surname><given-names>Y</given-names></name><name><surname>Misawa</surname><given-names>H</given-names></name></person-group>. <article-title>Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function</article-title>. <source>Life Sci</source> (<year>2012</year>) <volume>91</volume>(<issue>21&#x02013;22</issue>):<fpage>1027</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/j.lfs.2012.05.006</pub-id><?supplied-pmid 22659391?><pub-id pub-id-type="pmid">22659391</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosas-Ballina</surname><given-names>M</given-names></name><name><surname>Olofsson</surname><given-names>PS</given-names></name><name><surname>Ochani</surname><given-names>M</given-names></name><name><surname>Valdes-Ferrer</surname><given-names>SI</given-names></name><name><surname>Levine</surname><given-names>YA</given-names></name><name><surname>Reardon</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit</article-title>. <source>Science</source> (<year>2011</year>) <volume>334</volume>(<issue>6052</issue>):<fpage>98</fpage>&#x02013;<lpage>101</lpage>.<pub-id pub-id-type="doi">10.1126/science.1209985</pub-id><?supplied-pmid 21921156?><pub-id pub-id-type="pmid">21921156</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cosentino</surname><given-names>M</given-names></name><name><surname>Bombelli</surname><given-names>R</given-names></name><name><surname>Ferrari</surname><given-names>M</given-names></name><name><surname>Marino</surname><given-names>F</given-names></name><name><surname>Rasini</surname><given-names>E</given-names></name><name><surname>Maestroni</surname><given-names>GJ</given-names></name><etal/></person-group>
<article-title>HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines</article-title>. <source>Life Sci</source> (<year>2000</year>) <volume>68</volume>(<issue>3</issue>):<fpage>283</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="doi">10.1016/S0024-3205(00)00937-1</pub-id><?supplied-pmid 11191644?><pub-id pub-id-type="pmid">11191644</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tracey</surname><given-names>KJ</given-names></name></person-group>. <article-title>The inflammatory reflex</article-title>. <source>Nature</source> (<year>2002</year>) <volume>420</volume>(<issue>6917</issue>):<fpage>853</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nature01321</pub-id><?supplied-pmid 12490958?><pub-id pub-id-type="pmid">12490958</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tracey</surname><given-names>KJ</given-names></name></person-group>. <article-title>Physiology and immunology of the cholinergic antiinflammatory pathway</article-title>. <source>J Clin Invest</source> (<year>2007</year>) <volume>117</volume>(<issue>2</issue>):<fpage>289</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1172/JCI30555</pub-id><?supplied-pmid 17273548?><pub-id pub-id-type="pmid">17273548</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tracey</surname><given-names>KJ</given-names></name></person-group>
<article-title>Understanding immunity requires more than immunology</article-title>. <source>Nat Immunol</source> (<year>2010</year>) <volume>11</volume>(<issue>7</issue>):<fpage>561</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1038/ni0710-561</pub-id><pub-id pub-id-type="pmid">20562838</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borovikova</surname><given-names>LV</given-names></name><name><surname>Ivanova</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Botchkina</surname><given-names>GI</given-names></name><name><surname>Watkins</surname><given-names>LR</given-names></name><etal/></person-group>
<article-title>Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin</article-title>. <source>Nature</source> (<year>2000</year>) <volume>405</volume>(<issue>6785</issue>):<fpage>458</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1038/35013070</pub-id><?supplied-pmid 10839541?><pub-id pub-id-type="pmid">10839541</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ek</surname><given-names>M</given-names></name><name><surname>Kurosawa</surname><given-names>M</given-names></name><name><surname>Lundeberg</surname><given-names>T</given-names></name><name><surname>Ericsson</surname><given-names>A</given-names></name></person-group>. <article-title>Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins</article-title>. <source>J Neurosci</source> (<year>1998</year>) <volume>18</volume>(<issue>22</issue>):<fpage>9471</fpage>&#x02013;<lpage>9</lpage>.<?supplied-pmid 9801384?><pub-id pub-id-type="pmid">9801384</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermann</surname><given-names>GE</given-names></name><name><surname>Rogers</surname><given-names>RC</given-names></name></person-group>. <article-title>TNFalpha: a trigger of autonomic dysfunction</article-title>. <source>Neuroscientist</source> (<year>2008</year>) <volume>14</volume>(<issue>1</issue>):<fpage>53</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1177/1073858407305725</pub-id><?supplied-pmid 17911224?><pub-id pub-id-type="pmid">17911224</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Kleij</surname><given-names>H</given-names></name><name><surname>Charles</surname><given-names>N</given-names></name><name><surname>Karimi</surname><given-names>K</given-names></name><name><surname>Mao</surname><given-names>YK</given-names></name><name><surname>Foster</surname><given-names>J</given-names></name><name><surname>Janssen</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Evidence for neuronal expression of functional Fc (epsilon and gamma) receptors</article-title>. <source>J Allergy Clin Immunol</source> (<year>2010</year>) <volume>125</volume>(<issue>3</issue>):<fpage>757</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaci.2009.10.054</pub-id><pub-id pub-id-type="pmid">20132972</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>AJ</given-names></name><name><surname>O&#x02019;Donnell</surname><given-names>TA</given-names></name><name><surname>Blackshaw</surname><given-names>LA</given-names></name></person-group>. <article-title>P2X purinoceptor-induced sensitization of ferret vagal mechanoreceptors in oesophageal inflammation</article-title>. <source>J Physiol</source> (<year>2000</year>) <volume>523</volume>(<issue>Pt 2</issue>):<fpage>403</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-7793.2000.00403.x</pub-id><?supplied-pmid 10699084?><pub-id pub-id-type="pmid">10699084</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouns</surname><given-names>I</given-names></name><name><surname>Adriaensen</surname><given-names>D</given-names></name><name><surname>Burnstock</surname><given-names>G</given-names></name><name><surname>Timmermans</surname><given-names>JP</given-names></name></person-group>. <article-title>Intraepithelial vagal sensory nerve terminals in rat pulmonary neuroepithelial bodies express P2X(3) receptors</article-title>. <source>Am J Respir Cell Mol Biol</source> (<year>2000</year>) <volume>23</volume>(<issue>1</issue>):<fpage>52</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1165/ajrcmb.23.1.3936</pub-id><?supplied-pmid 10873153?><pub-id pub-id-type="pmid">10873153</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niijima</surname><given-names>A</given-names></name><name><surname>Hori</surname><given-names>T</given-names></name><name><surname>Katafuchi</surname><given-names>T</given-names></name><name><surname>Ichijo</surname><given-names>T</given-names></name></person-group>. <article-title>The effect of interleukin-1 beta on the efferent activity of the vagus nerve to the thymus</article-title>. <source>J Auton Nerv Syst</source> (<year>1995</year>) <volume>54</volume>(<issue>2</issue>):<fpage>137</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1016/0165-1838(95)00003-G</pub-id><?supplied-pmid 7499725?><pub-id pub-id-type="pmid">7499725</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niijima</surname><given-names>A</given-names></name></person-group>. <article-title>The afferent discharges from sensors for interleukin 1 beta in the hepatoportal system in the anesthetized rat</article-title>. <source>J Auton Nerv Syst</source> (<year>1996</year>) <volume>61</volume>(<issue>3</issue>):<fpage>287</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/S0165-1838(96)00098-7</pub-id><?supplied-pmid 8988487?><pub-id pub-id-type="pmid">8988487</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinberg</surname><given-names>BE</given-names></name><name><surname>Silverman</surname><given-names>HA</given-names></name><name><surname>Robbiati</surname><given-names>S</given-names></name><name><surname>Gunasekaran</surname><given-names>MK</given-names></name><name><surname>Tsaava</surname><given-names>T</given-names></name><name><surname>Battinelli</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Cytokine-specific neurograms in the sensory vagus nerve</article-title>. <source>Bioelectron Med</source> (<year>2016</year>) <volume>3</volume>:<fpage>7</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.15424/bioelectronmed.2016.00007</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname><given-names>RW</given-names></name><name><surname>Varma</surname><given-names>S</given-names></name><name><surname>Peng-Nemeroff</surname><given-names>T</given-names></name><name><surname>Sherry</surname><given-names>B</given-names></name><name><surname>Balakhaneh</surname><given-names>D</given-names></name><name><surname>Huston</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation</article-title>. <source>J Exp Med</source> (<year>2005</year>) <volume>201</volume>(<issue>7</issue>):<fpage>1113</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20040463</pub-id><?supplied-pmid 15809354?><pub-id pub-id-type="pmid">15809354</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Ochani</surname><given-names>M</given-names></name><name><surname>Amella</surname><given-names>CA</given-names></name><name><surname>Tanovic</surname><given-names>M</given-names></name><name><surname>Susarla</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation</article-title>. <source>Nature</source> (<year>2003</year>) <volume>421</volume>(<issue>6921</issue>):<fpage>384</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/nature01339</pub-id><?supplied-pmid 12508119?><pub-id pub-id-type="pmid">12508119</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liao</surname><given-names>H</given-names></name><name><surname>Ochani</surname><given-names>M</given-names></name><name><surname>Justiniani</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis</article-title>. <source>Nat Med</source> (<year>2004</year>) <volume>10</volume>(<issue>11</issue>):<fpage>1216</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1038/nm1124</pub-id><?supplied-pmid 15502843?><pub-id pub-id-type="pmid">15502843</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jonge</surname><given-names>WJ</given-names></name><name><surname>van der Zanden</surname><given-names>EP</given-names></name><name><surname>The</surname><given-names>FO</given-names></name><name><surname>Bijlsma</surname><given-names>MF</given-names></name><name><surname>van Westerloo</surname><given-names>DJ</given-names></name><name><surname>Bennink</surname><given-names>RJ</given-names></name><etal/></person-group>
<article-title>Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway</article-title>. <source>Nat Immunol</source> (<year>2005</year>) <volume>6</volume>(<issue>8</issue>):<fpage>844</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1038/ni0905-954b</pub-id><?supplied-pmid 16025117?><pub-id pub-id-type="pmid">16025117</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vida</surname><given-names>G</given-names></name><name><surname>Pena</surname><given-names>G</given-names></name><name><surname>Kanashiro</surname><given-names>A</given-names></name><name><surname>Thompson-Bonilla Mdel</surname><given-names>R</given-names></name><name><surname>Palange</surname><given-names>D</given-names></name><name><surname>Deitch</surname><given-names>EA</given-names></name><etal/></person-group>
<article-title>Beta2-adrenoreceptors of regulatory lymphocytes are essential for vagal neuromodulation of the innate immune system</article-title>. <source>FASEB J</source> (<year>2011</year>) <volume>25</volume>(<issue>12</issue>):<fpage>4476</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1096/fj.11-191007</pub-id><pub-id pub-id-type="pmid">21840939</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huston</surname><given-names>JM</given-names></name><name><surname>Ochani</surname><given-names>M</given-names></name><name><surname>Rosas-Ballina</surname><given-names>M</given-names></name><name><surname>Liao</surname><given-names>H</given-names></name><name><surname>Ochani</surname><given-names>K</given-names></name><name><surname>Pavlov</surname><given-names>VA</given-names></name><etal/></person-group>
<article-title>Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis</article-title>. <source>J Exp Med</source> (<year>2006</year>) <volume>203</volume>(<issue>7</issue>):<fpage>1623</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20052362</pub-id><?supplied-pmid 16785311?><pub-id pub-id-type="pmid">16785311</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellinger</surname><given-names>DL</given-names></name><name><surname>Lorton</surname><given-names>D</given-names></name><name><surname>Hamill</surname><given-names>RW</given-names></name><name><surname>Felten</surname><given-names>SY</given-names></name><name><surname>Felten</surname><given-names>DL</given-names></name></person-group>
<article-title>Acetylcholinesterase staining and choline acetyltransferase activity in the young adult rat spleen: lack of evidence for cholinergic innervation</article-title>. <source>Brain Behav Immun</source> (<year>1993</year>) <volume>7</volume>(<issue>3</issue>):<fpage>191</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="doi">10.1006/brbi.1993.1021</pub-id><pub-id pub-id-type="pmid">8219410</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nance</surname><given-names>DM</given-names></name><name><surname>Sanders</surname><given-names>VM</given-names></name></person-group>. <article-title>Autonomic innervation and regulation of the immune system (1987-2007)</article-title>. <source>Brain Behav Immun</source> (<year>2007</year>) <volume>21</volume>(<issue>6</issue>):<fpage>736</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2007.03.008</pub-id><?supplied-pmid 17467231?><pub-id pub-id-type="pmid">17467231</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchino</surname><given-names>S</given-names></name><name><surname>Kellum</surname><given-names>JA</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><name><surname>Doig</surname><given-names>GS</given-names></name><name><surname>Morimatsu</surname><given-names>H</given-names></name><name><surname>Morgera</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Acute renal failure in critically ill patients: a multinational, multicenter study</article-title>. <source>JAMA</source> (<year>2005</year>) <volume>294</volume>(<issue>7</issue>):<fpage>813</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1001/jama.294.7.813</pub-id><?supplied-pmid 16106006?><pub-id pub-id-type="pmid">16106006</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>RL</given-names></name><name><surname>Burdmann</surname><given-names>EA</given-names></name><name><surname>Cerda</surname><given-names>J</given-names></name><name><surname>Feehally</surname><given-names>J</given-names></name><name><surname>Finkelstein</surname><given-names>F</given-names></name><name><surname>Garcia-Garcia</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study</article-title>. <source>Lancet</source> (<year>2016</year>) <volume>387</volume>(<issue>10032</issue>):<fpage>2017</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(16)30240-9</pub-id><?supplied-pmid 27086173?><pub-id pub-id-type="pmid">27086173</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheuermeyer</surname><given-names>FX</given-names></name><name><surname>Grafstein</surname><given-names>E</given-names></name><name><surname>Rowe</surname><given-names>B</given-names></name><name><surname>Cheyne</surname><given-names>J</given-names></name><name><surname>Grunau</surname><given-names>B</given-names></name><name><surname>Bradford</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>The clinical epidemiology and 30-day outcomes of emergency department patients with acute kidney injury</article-title>. <source>Can J Kidney Health Dis</source> (<year>2017</year>) <volume>4</volume>:<fpage>2054358117703985</fpage>.<pub-id pub-id-type="doi">10.1177/2054358117703985</pub-id><?supplied-pmid 28491339?><pub-id pub-id-type="pmid">28491339</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinsey</surname><given-names>GR</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Okusa</surname><given-names>MD</given-names></name></person-group>. <article-title>Inflammation in acute kidney injury</article-title>. <source>Nephron Exp Nephrol</source> (<year>2008</year>) <volume>109</volume>(<issue>4</issue>):<fpage>e102</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1159/000142934</pub-id><?supplied-pmid 18802372?><pub-id pub-id-type="pmid">18802372</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabb</surname><given-names>H</given-names></name><name><surname>Griffin</surname><given-names>MD</given-names></name><name><surname>McKay</surname><given-names>DB</given-names></name><name><surname>Swaminathan</surname><given-names>S</given-names></name><name><surname>Pickkers</surname><given-names>P</given-names></name><name><surname>Rosner</surname><given-names>MH</given-names></name><etal/></person-group>
<article-title>Inflammation in AKI: current understanding, key questions, and knowledge gaps</article-title>. <source>J Am Soc Nephrol</source> (<year>2016</year>) <volume>27</volume>(<issue>2</issue>):<fpage>371</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1681/ASN.2015030261</pub-id><?supplied-pmid 26561643?><pub-id pub-id-type="pmid">26561643</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>HR</given-names></name><name><surname>Rabb</surname><given-names>H</given-names></name></person-group>. <article-title>Immune cells in experimental acute kidney injury</article-title>. <source>Nat Rev Nephrol</source> (<year>2015</year>) <volume>11</volume>(<issue>2</issue>):<fpage>88</fpage>&#x02013;<lpage>101</lpage>.<pub-id pub-id-type="doi">10.1038/nrneph.2014.180</pub-id><?supplied-pmid 25331787?><pub-id pub-id-type="pmid">25331787</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Q</given-names></name><name><surname>Harris</surname><given-names>DC</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>. <article-title>Macrophages in kidney injury, inflammation, and fibrosis</article-title>. <source>Physiology (Bethesda)</source> (<year>2015</year>) <volume>30</volume>(<issue>3</issue>):<fpage>183</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1152/physiol.00046.2014</pub-id><?supplied-pmid 25933819?><pub-id pub-id-type="pmid">25933819</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>HR</given-names></name><name><surname>Rabb</surname><given-names>H</given-names></name></person-group>
<article-title>The innate immune response in ischemic acute kidney injury</article-title>. <source>Clin Immunol</source> (<year>2009</year>) <volume>130</volume>(<issue>1</issue>):<fpage>41</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1016/j.clim.2008.08.016</pub-id><pub-id pub-id-type="pmid">18922742</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huen</surname><given-names>SC</given-names></name><name><surname>Cantley</surname><given-names>LG</given-names></name></person-group>. <article-title>Macrophage-mediated injury and repair after ischemic kidney injury</article-title>. <source>Pediatr Nephrol</source> (<year>2015</year>) <volume>30</volume>(<issue>2</issue>):<fpage>199</fpage>&#x02013;<lpage>209</lpage>.<pub-id pub-id-type="doi">10.1007/s00467-013-2726-y</pub-id><?supplied-pmid 24442822?><pub-id pub-id-type="pmid">24442822</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinsey</surname><given-names>GR</given-names></name><name><surname>Sharma</surname><given-names>R</given-names></name><name><surname>Okusa</surname><given-names>MD</given-names></name></person-group>
<article-title>Regulatory T cells in AKI</article-title>. <source>J Am Soc Nephrol</source> (<year>2013</year>) <volume>24</volume>(<issue>11</issue>):<fpage>1720</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1681/ASN.2013050502</pub-id><pub-id pub-id-type="pmid">24136922</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinsey</surname><given-names>GR</given-names></name><name><surname>Okusa</surname><given-names>MD</given-names></name></person-group>. <article-title>Expanding role of T cells in acute kidney injury</article-title>. <source>Curr Opin Nephrol Hypertens</source> (<year>2014</year>) <volume>23</volume>(<issue>1</issue>):<fpage>9</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1097/01.mnh.0000436695.29173.de</pub-id><?supplied-pmid 24231312?><pub-id pub-id-type="pmid">24231312</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>HR</given-names></name><name><surname>Gandolfo</surname><given-names>MT</given-names></name><name><surname>Ko</surname><given-names>GJ</given-names></name><name><surname>Satpute</surname><given-names>SR</given-names></name><name><surname>Racusen</surname><given-names>L</given-names></name><name><surname>Rabb</surname><given-names>H</given-names></name></person-group>. <article-title>B cells limit repair after ischemic acute kidney injury</article-title>. <source>J Am Soc Nephrol</source> (<year>2010</year>) <volume>21</volume>(<issue>4</issue>):<fpage>654</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1681/ASN.2009020182</pub-id><?supplied-pmid 20203156?><pub-id pub-id-type="pmid">20203156</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Abe</surname><given-names>C</given-names></name><name><surname>Sung</surname><given-names>SS</given-names></name><name><surname>Moscalu</surname><given-names>S</given-names></name><name><surname>Jankowski</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Vagus nerve stimulation mediates protection from kidney ischemia-reperfusion injury through alpha7nAChR+ splenocytes</article-title>. <source>J Clin Invest</source> (<year>2016</year>) <volume>126</volume>(<issue>5</issue>):<fpage>1939</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1172/JCI83658</pub-id><pub-id pub-id-type="pmid">27088805</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imig</surname><given-names>JD</given-names></name><name><surname>Ryan</surname><given-names>MJ</given-names></name></person-group>. <article-title>Immune and inflammatory role in renal disease</article-title>. <source>Compr Physiol</source> (<year>2013</year>) <volume>3</volume>(<issue>2</issue>):<fpage>957</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1002/cphy.c120028</pub-id><?supplied-pmid 23720336?><pub-id pub-id-type="pmid">23720336</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurts</surname><given-names>C</given-names></name><name><surname>Panzer</surname><given-names>U</given-names></name><name><surname>Anders</surname><given-names>HJ</given-names></name><name><surname>Rees</surname><given-names>AJ</given-names></name></person-group>. <article-title>The immune system and kidney disease: basic concepts and clinical implications</article-title>. <source>Nat Rev Immunol</source> (<year>2013</year>) <volume>13</volume>(<issue>10</issue>):<fpage>738</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1038/nri3523</pub-id><?supplied-pmid 24037418?><pub-id pub-id-type="pmid">24037418</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pichler</surname><given-names>R</given-names></name><name><surname>Afkarian</surname><given-names>M</given-names></name><name><surname>Dieter</surname><given-names>BP</given-names></name><name><surname>Tuttle</surname><given-names>KR</given-names></name></person-group>. <article-title>Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets</article-title>. <source>Am J Physiol Renal Physiol</source> (<year>2017</year>) <volume>312</volume>(<issue>4</issue>):<fpage>F716</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1152/ajprenal.00314.2016</pub-id><?supplied-pmid 27558558?><pub-id pub-id-type="pmid">27558558</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suarez-Fueyo</surname><given-names>A</given-names></name><name><surname>Bradley</surname><given-names>SJ</given-names></name><name><surname>Klatzmann</surname><given-names>D</given-names></name><name><surname>Tsokos</surname><given-names>GC</given-names></name></person-group>. <article-title>T cells and autoimmune kidney disease</article-title>. <source>Nat Rev Nephrol</source> (<year>2017</year>) <volume>13</volume>(<issue>6</issue>):<fpage>329</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1038/nrneph.2017.34</pub-id><?supplied-pmid 28287110?><pub-id pub-id-type="pmid">28287110</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duffield</surname><given-names>JS</given-names></name></person-group>. <article-title>Macrophages and immunologic inflammation of the kidney</article-title>. <source>Semin Nephrol</source> (<year>2010</year>) <volume>30</volume>(<issue>3</issue>):<fpage>234</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1016/j.semnephrol.2010.03.003</pub-id><?supplied-pmid 20620669?><pub-id pub-id-type="pmid">20620669</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeger</surname><given-names>S</given-names></name><name><surname>Fontana</surname><given-names>J</given-names></name><name><surname>Jarczyk</surname><given-names>J</given-names></name><name><surname>Selhorst</surname><given-names>J</given-names></name><name><surname>Waldherr</surname><given-names>R</given-names></name><name><surname>Kramer</surname><given-names>BK</given-names></name><etal/></person-group>
<article-title>Vagal stimulation in brain dead donor rats decreases chronic allograft nephropathy in recipients</article-title>. <source>Nephrol Dial Transplant</source> (<year>2014</year>) <volume>29</volume>(<issue>3</issue>):<fpage>544</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1093/ndt/gft451</pub-id><?supplied-pmid 24235086?><pub-id pub-id-type="pmid">24235086</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gigliotti</surname><given-names>JC</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Ye</surname><given-names>H</given-names></name><name><surname>Bajwa</surname><given-names>A</given-names></name><name><surname>Chattrabhuti</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway</article-title>. <source>J Am Soc Nephrol</source> (<year>2013</year>) <volume>24</volume>(<issue>9</issue>):<fpage>1451</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1681/ASN.2013010084</pub-id><?supplied-pmid 23907510?><pub-id pub-id-type="pmid">23907510</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gigliotti</surname><given-names>JC</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Bajwa</surname><given-names>A</given-names></name><name><surname>Ye</surname><given-names>H</given-names></name><name><surname>Mace</surname><given-names>EH</given-names></name><name><surname>Hossack</surname><given-names>JA</given-names></name><etal/></person-group>
<article-title>Ultrasound modulates the splenic neuroimmune axis in attenuating AKI</article-title>. <source>J Am Soc Nephrol</source> (<year>2015</year>) <volume>26</volume>(<issue>10</issue>):<fpage>2470</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1681/ASN.2014080769</pub-id><?supplied-pmid 25644106?><pub-id pub-id-type="pmid">25644106</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAllen</surname><given-names>RM</given-names></name><name><surname>Cook</surname><given-names>AD</given-names></name><name><surname>Khiew</surname><given-names>HW</given-names></name><name><surname>Martelli</surname><given-names>D</given-names></name><name><surname>Hamilton</surname><given-names>JA</given-names></name></person-group>. <article-title>The interface between cholinergic pathways and the immune system and its relevance to arthritis</article-title>. <source>Arthritis Res Ther</source> (<year>2015</year>) <volume>17</volume>:<fpage>87</fpage>.<pub-id pub-id-type="doi">10.1186/s13075-015-0597-2</pub-id><?supplied-pmid 25889979?><pub-id pub-id-type="pmid">25889979</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goverse</surname><given-names>G</given-names></name><name><surname>Stakenborg</surname><given-names>M</given-names></name><name><surname>Matteoli</surname><given-names>G</given-names></name></person-group>. <article-title>The intestinal cholinergic anti-inflammatory pathway</article-title>. <source>J Physiol</source> (<year>2016</year>) <volume>594</volume>(<issue>20</issue>):<fpage>5771</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1113/JP271537</pub-id><?supplied-pmid 26959627?><pub-id pub-id-type="pmid">26959627</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Westerloo</surname><given-names>DJ</given-names></name><name><surname>Giebelen</surname><given-names>IA</given-names></name><name><surname>Florquin</surname><given-names>S</given-names></name><name><surname>Bruno</surname><given-names>MJ</given-names></name><name><surname>Larosa</surname><given-names>GJ</given-names></name><name><surname>Ulloa</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice</article-title>. <source>Gastroenterology</source> (<year>2006</year>) <volume>130</volume>(<issue>6</issue>):<fpage>1822</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1053/j.gastro.2006.02.022</pub-id><?supplied-pmid 16697744?><pub-id pub-id-type="pmid">16697744</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernik</surname><given-names>TR</given-names></name><name><surname>Friedman</surname><given-names>SG</given-names></name><name><surname>Ochani</surname><given-names>M</given-names></name><name><surname>DiRaimo</surname><given-names>R</given-names></name><name><surname>Ulloa</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Pharmacological stimulation of the cholinergic antiinflammatory pathway</article-title>. <source>J Exp Med</source> (<year>2002</year>) <volume>195</volume>(<issue>6</issue>):<fpage>781</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20011714</pub-id><?supplied-pmid 11901203?><pub-id pub-id-type="pmid">11901203</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Opland</surname><given-names>D</given-names></name><name><surname>Tsai</surname><given-names>S</given-names></name><name><surname>Luk</surname><given-names>CT</given-names></name><name><surname>Schroer</surname><given-names>SA</given-names></name><name><surname>Allison</surname><given-names>MB</given-names></name><etal/></person-group>
<article-title>Pten deletion in RIP-Cre neurons protects against type 2 diabetes by activating the anti-inflammatory reflex</article-title>. <source>Nat Med</source> (<year>2014</year>) <volume>20</volume>(<issue>5</issue>):<fpage>484</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1038/nm.3527</pub-id><?supplied-pmid 24747746?><pub-id pub-id-type="pmid">24747746</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carnevale</surname><given-names>D</given-names></name><name><surname>Perrotta</surname><given-names>M</given-names></name><name><surname>Pallante</surname><given-names>F</given-names></name><name><surname>Fardella</surname><given-names>V</given-names></name><name><surname>Iacobucci</surname><given-names>R</given-names></name><name><surname>Fardella</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>A cholinergic-sympathetic pathway primes immunity in hypertension and mediates brain-to-spleen communication</article-title>. <source>Nat Commun</source> (<year>2016</year>) <volume>7</volume>:<fpage>13035</fpage>.<pub-id pub-id-type="doi">10.1038/ncomms13035</pub-id><?supplied-pmid 27676657?><pub-id pub-id-type="pmid">27676657</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matteoli</surname><given-names>G</given-names></name><name><surname>Gomez-Pinilla</surname><given-names>PJ</given-names></name><name><surname>Nemethova</surname><given-names>A</given-names></name><name><surname>Di Giovangiulio</surname><given-names>M</given-names></name><name><surname>Cailotto</surname><given-names>C</given-names></name><name><surname>van Bree</surname><given-names>SH</given-names></name><etal/></person-group>
<article-title>A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen</article-title>. <source>Gut</source> (<year>2014</year>) <volume>63</volume>(<issue>6</issue>):<fpage>938</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1136/gutjnl-2013-304676</pub-id><?supplied-pmid 23929694?><pub-id pub-id-type="pmid">23929694</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Involvement of MAPK/NF-kappaB signaling in the activation of the cholinergic anti-inflammatory pathway in experimental colitis by chronic vagus nerve stimulation</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>(<issue>8</issue>):<fpage>e69424</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0069424</pub-id><pub-id pub-id-type="pmid">23936328</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>The</surname><given-names>FO</given-names></name><name><surname>Boeckxstaens</surname><given-names>GE</given-names></name><name><surname>Snoek</surname><given-names>SA</given-names></name><name><surname>Cash</surname><given-names>JL</given-names></name><name><surname>Bennink</surname><given-names>R</given-names></name><name><surname>Larosa</surname><given-names>GJ</given-names></name><etal/></person-group>
<article-title>Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice</article-title>. <source>Gastroenterology</source> (<year>2007</year>) <volume>133</volume>(<issue>4</issue>):<fpage>1219</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1053/j.gastro.2007.07.022</pub-id><?supplied-pmid 17919496?><pub-id pub-id-type="pmid">17919496</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghia</surname><given-names>JE</given-names></name><name><surname>Blennerhassett</surname><given-names>P</given-names></name><name><surname>Kumar-Ondiveeran</surname><given-names>H</given-names></name><name><surname>Verdu</surname><given-names>EF</given-names></name><name><surname>Collins</surname><given-names>SM</given-names></name></person-group>. <article-title>The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model</article-title>. <source>Gastroenterology</source> (<year>2006</year>) <volume>131</volume>(<issue>4</issue>):<fpage>1122</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1053/j.gastro.2006.08.016</pub-id><?supplied-pmid 17030182?><pub-id pub-id-type="pmid">17030182</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borovikova</surname><given-names>LV</given-names></name><name><surname>Ivanova</surname><given-names>S</given-names></name><name><surname>Nardi</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Ombrellino</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation</article-title>. <source>Auton Neurosci</source> (<year>2000</year>) <volume>85</volume>(<issue>1&#x02013;3</issue>):<fpage>141</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/S1566-0702(00)00233-2</pub-id><?supplied-pmid 11189021?><pub-id pub-id-type="pmid">11189021</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Han</surname><given-names>D</given-names></name><name><surname>Tang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Dai</surname><given-names>K</given-names></name></person-group>. <article-title>Inhibition of the development of collagen-induced arthritis in Wistar rats through vagus nerve suspension: a 3-month observation</article-title>. <source>Inflamm Res</source> (<year>2008</year>) <volume>57</volume>(<issue>7</issue>):<fpage>322</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1007/s00011-008-8070-1</pub-id><?supplied-pmid 18607536?><pub-id pub-id-type="pmid">18607536</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>YA</given-names></name><name><surname>Koopman</surname><given-names>FA</given-names></name><name><surname>Faltys</surname><given-names>M</given-names></name><name><surname>Caravaca</surname><given-names>A</given-names></name><name><surname>Bendele</surname><given-names>A</given-names></name><name><surname>Zitnik</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis</article-title>. <source>PLoS One</source> (<year>2014</year>) <volume>9</volume>(<issue>8</issue>):<fpage>e104530</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0104530</pub-id><?supplied-pmid 25110981?><pub-id pub-id-type="pmid">25110981</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres-Rosas</surname><given-names>R</given-names></name><name><surname>Yehia</surname><given-names>G</given-names></name><name><surname>Pena</surname><given-names>G</given-names></name><name><surname>Mishra</surname><given-names>P</given-names></name><name><surname>del Rocio Thompson-Bonilla</surname><given-names>M</given-names></name><name><surname>Moreno-Eutimio</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>Dopamine mediates vagal modulation of the immune system by electroacupuncture</article-title>. <source>Nat Med</source> (<year>2014</year>) <volume>20</volume>(<issue>3</issue>):<fpage>291</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/nm.3479</pub-id><?supplied-pmid 24562381?><pub-id pub-id-type="pmid">24562381</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martelli</surname><given-names>D</given-names></name><name><surname>Yao</surname><given-names>ST</given-names></name><name><surname>McKinley</surname><given-names>MJ</given-names></name><name><surname>McAllen</surname><given-names>RM</given-names></name></person-group>. <article-title>Reflex control of inflammation by sympathetic nerves, not the vagus</article-title>. <source>J Physiol</source> (<year>2014</year>) <volume>592</volume>(<issue>Pt 7</issue>):<fpage>1677</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1113/jphysiol.2013.268573</pub-id><?supplied-pmid 24421357?><pub-id pub-id-type="pmid">24421357</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reardon</surname><given-names>C</given-names></name><name><surname>Duncan</surname><given-names>GS</given-names></name><name><surname>Brustle</surname><given-names>A</given-names></name><name><surname>Brenner</surname><given-names>D</given-names></name><name><surname>Tusche</surname><given-names>MW</given-names></name><name><surname>Olofsson</surname><given-names>PS</given-names></name><etal/></person-group>
<article-title>Lymphocyte-derived ACh regulates local innate but not adaptive immunity</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2013</year>) <volume>110</volume>(<issue>4</issue>):<fpage>1410</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1221655110</pub-id><?supplied-pmid 23297238?><pub-id pub-id-type="pmid">23297238</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabanyi</surname><given-names>I</given-names></name><name><surname>Muller</surname><given-names>PA</given-names></name><name><surname>Feighery</surname><given-names>L</given-names></name><name><surname>Oliveira</surname><given-names>TY</given-names></name><name><surname>Costa-Pinto</surname><given-names>FA</given-names></name><name><surname>Mucida</surname><given-names>D</given-names></name></person-group>. <article-title>Neuro-immune interactions drive tissue programming in intestinal macrophages</article-title>. <source>Cell</source> (<year>2016</year>) <volume>164</volume>(<issue>3</issue>):<fpage>378</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2015.12.023</pub-id><?supplied-pmid 26777404?><pub-id pub-id-type="pmid">26777404</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montgomery</surname><given-names>KL</given-names></name><name><surname>Iyer</surname><given-names>SM</given-names></name><name><surname>Christensen</surname><given-names>AJ</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name><name><surname>Delp</surname><given-names>SL</given-names></name></person-group>
<article-title>Beyond the brain: optogenetic control in the spinal cord and peripheral nervous system</article-title>. <source>Sci Transl Med</source> (<year>2016</year>) <volume>8</volume>(<issue>337</issue>):<fpage>337rv5</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aad7577</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagel</surname><given-names>G</given-names></name><name><surname>Ollig</surname><given-names>D</given-names></name><name><surname>Fuhrmann</surname><given-names>M</given-names></name><name><surname>Kateriya</surname><given-names>S</given-names></name><name><surname>Musti</surname><given-names>AM</given-names></name><name><surname>Bamberg</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Channelrhodopsin-1: a light-gated proton channel in green algae</article-title>. <source>Science</source> (<year>2002</year>) <volume>296</volume>(<issue>5577</issue>):<fpage>2395</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1126/science.1072068</pub-id><?supplied-pmid 12089443?><pub-id pub-id-type="pmid">12089443</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagel</surname><given-names>G</given-names></name><name><surname>Szellas</surname><given-names>T</given-names></name><name><surname>Huhn</surname><given-names>W</given-names></name><name><surname>Kateriya</surname><given-names>S</given-names></name><name><surname>Adeishvili</surname><given-names>N</given-names></name><name><surname>Berthold</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Channelrhodopsin-2, a directly light-gated cation-selective membrane channel</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2003</year>) <volume>100</volume>(<issue>24</issue>):<fpage>13940</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1936192100</pub-id><?supplied-pmid 14615590?><pub-id pub-id-type="pmid">14615590</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyden</surname><given-names>ES</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Bamberg</surname><given-names>E</given-names></name><name><surname>Nagel</surname><given-names>G</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name></person-group>. <article-title>Millisecond-timescale, genetically targeted optical control of neural activity</article-title>. <source>Nat Neurosci</source> (<year>2005</year>) <volume>8</volume>(<issue>9</issue>):<fpage>1263</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/nn1525</pub-id><?supplied-pmid 16116447?><pub-id pub-id-type="pmid">16116447</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Boyden</surname><given-names>ES</given-names></name></person-group>. <article-title>Multiple-color optical activation, silencing, and desynchronization of neural activity, with single-spike temporal resolution</article-title>. <source>PLoS One</source> (<year>2007</year>) <volume>2</volume>(<issue>3</issue>):<fpage>e299</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0000299</pub-id><?supplied-pmid 17375185?><pub-id pub-id-type="pmid">17375185</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deisseroth</surname><given-names>K</given-names></name></person-group>
<article-title>Optogenetics</article-title>. <source>Nat Methods</source> (<year>2011</year>) <volume>8</volume>(<issue>1</issue>):<fpage>26</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nmeth.f.324</pub-id><pub-id pub-id-type="pmid">21191368</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>RB</given-names></name><name><surname>Strochlic</surname><given-names>DE</given-names></name><name><surname>Williams</surname><given-names>EK</given-names></name><name><surname>Umans</surname><given-names>BD</given-names></name><name><surname>Liberles</surname><given-names>SD</given-names></name></person-group>. <article-title>Vagal sensory neuron subtypes that differentially control breathing</article-title>. <source>Cell</source> (<year>2015</year>) <volume>161</volume>(<issue>3</issue>):<fpage>622</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2015.03.022</pub-id><?supplied-pmid 25892222?><pub-id pub-id-type="pmid">25892222</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>EK</given-names></name><name><surname>Chang</surname><given-names>RB</given-names></name><name><surname>Strochlic</surname><given-names>DE</given-names></name><name><surname>Umans</surname><given-names>BD</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name><name><surname>Liberles</surname><given-names>SD</given-names></name></person-group>. <article-title>Sensory neurons that detect stretch and nutrients in the digestive system</article-title>. <source>Cell</source> (<year>2016</year>) <volume>166</volume>(<issue>1</issue>):<fpage>209</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2016.05.011</pub-id><?supplied-pmid 27238020?><pub-id pub-id-type="pmid">27238020</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>C</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Inglis</surname><given-names>MA</given-names></name><name><surname>Viar</surname><given-names>KE</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Ye</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>C1 neurons mediate a stress-induced anti-inflammatory reflex in mice</article-title>. <source>Nat Neurosci</source> (<year>2017</year>) <volume>20</volume>(<issue>5</issue>):<fpage>700</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nn.4526</pub-id><?supplied-pmid 28288124?><pub-id pub-id-type="pmid">28288124</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyenet</surname><given-names>PG</given-names></name><name><surname>Stornetta</surname><given-names>RL</given-names></name><name><surname>Bochorishvili</surname><given-names>G</given-names></name><name><surname>Depuy</surname><given-names>SD</given-names></name><name><surname>Burke</surname><given-names>PG</given-names></name><name><surname>Abbott</surname><given-names>SB</given-names></name></person-group>. <article-title>C1 neurons: the body&#x02019;s EMTs</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source> (<year>2013</year>) <volume>305</volume>(<issue>3</issue>):<fpage>R187</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="doi">10.1152/ajpregu.00054.2013</pub-id><?supplied-pmid 23697799?><pub-id pub-id-type="pmid">23697799</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Menachem</surname><given-names>E</given-names></name><name><surname>Revesz</surname><given-names>D</given-names></name><name><surname>Simon</surname><given-names>BJ</given-names></name><name><surname>Silberstein</surname><given-names>S</given-names></name></person-group>. <article-title>Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability</article-title>. <source>Eur J Neurol</source> (<year>2015</year>) <volume>22</volume>(<issue>9</issue>):<fpage>1260</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/ene.12629</pub-id><?supplied-pmid 25614179?><pub-id pub-id-type="pmid">25614179</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kox</surname><given-names>M</given-names></name><name><surname>van Eijk</surname><given-names>LT</given-names></name><name><surname>Verhaak</surname><given-names>T</given-names></name><name><surname>Frenzel</surname><given-names>T</given-names></name><name><surname>Kiers</surname><given-names>HD</given-names></name><name><surname>Gerretsen</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Transvenous vagus nerve stimulation does not modulate the innate immune response during experimental human endotoxemia: a randomized controlled study</article-title>. <source>Arthritis Res Ther</source> (<year>2015</year>) <volume>17</volume>:<fpage>150</fpage><pub-id pub-id-type="doi">10.1186/s13075-015-0667-5</pub-id><pub-id pub-id-type="pmid">26049730</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koopman</surname><given-names>FA</given-names></name><name><surname>Chavan</surname><given-names>SS</given-names></name><name><surname>Miljko</surname><given-names>S</given-names></name><name><surname>Grazio</surname><given-names>S</given-names></name><name><surname>Sokolovic</surname><given-names>S</given-names></name><name><surname>Schuurman</surname><given-names>PR</given-names></name><etal/></person-group>
<article-title>Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2016</year>) <volume>113</volume>(<issue>29</issue>):<fpage>8284</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1605635113</pub-id><?supplied-pmid 27382171?><pub-id pub-id-type="pmid">27382171</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonaz</surname><given-names>B</given-names></name><name><surname>Sinniger</surname><given-names>V</given-names></name><name><surname>Hoffmann</surname><given-names>D</given-names></name><name><surname>Clarencon</surname><given-names>D</given-names></name><name><surname>Mathieu</surname><given-names>N</given-names></name><name><surname>Dantzer</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Chronic vagus nerve stimulation in Crohn&#x02019;s disease: a 6-month follow-up pilot study</article-title>. <source>Neurogastroenterol Motil</source> (<year>2016</year>) <volume>28</volume>(<issue>6</issue>):<fpage>948</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1111/nmo.12792</pub-id><?supplied-pmid 26920654?><pub-id pub-id-type="pmid">26920654</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ay</surname><given-names>I</given-names></name><name><surname>Nasser</surname><given-names>R</given-names></name><name><surname>Simon</surname><given-names>B</given-names></name><name><surname>Ay</surname><given-names>H</given-names></name></person-group>. <article-title>Transcutaneous cervical vagus nerve stimulation ameliorates acute ischemic injury in rats</article-title>. <source>Brain Stimul</source> (<year>2016</year>) <volume>9</volume>(<issue>2</issue>):<fpage>166</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1016/j.brs.2015.11.008</pub-id><?supplied-pmid 26723020?><pub-id pub-id-type="pmid">26723020</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerman</surname><given-names>I</given-names></name><name><surname>Hauger</surname><given-names>R</given-names></name><name><surname>Sorkin</surname><given-names>L</given-names></name><name><surname>Proudfoot</surname><given-names>J</given-names></name><name><surname>Davis</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Noninvasive transcutaneous vagus nerve stimulation decreases whole blood culture-derived cytokines and chemokines: a randomized, blinded, healthy control pilot trial</article-title>. <source>Neuromodulation</source> (<year>2016</year>) <volume>19</volume>(<issue>3</issue>):<fpage>283</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1111/ner.12398</pub-id><?supplied-pmid 26990318?><pub-id pub-id-type="pmid">26990318</pub-id></mixed-citation></ref></ref-list></back></article>